These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21601132)

  • 21. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands.
    Marogna M; Massolo A; Colombo F; Isella P; Bruno M; Falagiani P
    Allergol Immunopathol (Madr); 2011; 39(2):60-7. PubMed ID: 21216083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
    Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
    J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term benefits of specific immunotherapy (SIT).
    Olaguibel JM
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():39-41. PubMed ID: 19221617
    [No Abstract]   [Full Text] [Related]  

  • 26. Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy.
    Tabar AI; Arroabarren E; Echechipía S; García BE; Martin S; Alvarez-Puebla MJ
    J Allergy Clin Immunol; 2011 Jan; 127(1):57-63, 63.e1-3. PubMed ID: 21211641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum-specific IgE and allergen immunotherapy in allergic children.
    Tosca M; Silvestri M; Accogli A; Rossi GA; Ciprandi G
    Immunotherapy; 2014; 6(1):29-33. PubMed ID: 24341881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublingual immunotherapy in children. Re: Marcucci et al.
    de Bot C; Moed H; van der Wouden JC
    Pediatr Allergy Immunol; 2006 Jun; 17(4):315; author reply 316-7. PubMed ID: 16771788
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.
    Canonica GW; Virchow JC; Zieglmayer P; Ljørring C; Smith IM; Mosbech H
    Expert Rev Clin Immunol; 2016 Aug; 12(8):805-15. PubMed ID: 27322777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis.
    Mun SJ; Shin JM; Han DH; Kim JW; Kim DY; Lee CH; Min YG; Rhee CS
    Int Forum Allergy Rhinol; 2013 Mar; 3(3):177-83. PubMed ID: 23044892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
    Harmanci K; Razi CH; Toyran M; Kanmaz G; Cengizlier MR
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):7-13. PubMed ID: 20527510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and safety of specific sublingual immunotherapy in children with allergic asthma and rhinitis].
    Chen HW; Chen YY; Bao ZL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):223-226. PubMed ID: 29871228
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of sublingual immunotherapy in Asian children.
    Park IH; Hong SM; Lee HM
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tablet-based sublingual immunotherapy for respiratory allergy.
    Prieto L
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():30-35. PubMed ID: 29146015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sublingual immunotherapy with allergenic extract of Dermatophagoides pteronyssinus in asthmatic children].
    Rodríguez Santos O
    Rev Alerg Mex; 2004; 51(5):177-80. PubMed ID: 15794407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children.
    Queirós MG; Silva DA; Siman IL; Ynoue LH; Araújo NS; Pereira FL; Almeida KC; Miranda JS; Pena JD; Cunha-Junior JP; Taketomi EA
    Pediatr Allergy Immunol; 2013 Dec; 24(8):752-61. PubMed ID: 24299565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.